cancer immunotherapy
BioInvent and MSD to evaluate new treatment for metastatic melanoma
BioInvent, known for its innovative cancer immunotherapies, is expanding its collaboration with MSD to test BI-1607 in combination with ipilimumab...
Elicera updates in conjunction with Cancer Immunotherapy Month
June is celebrated globally as Cancer Immunotherapy Month in...
Intervju
Evaxion presents new strategic focus
Now that Per Norlén has taken over as...
Intervju
RhoVac's clinical cancer study is complete
RhoVac's first clinical study was completed today, thus...
Dual-acting nanoparticles can enhance the effectiveness of cancer immunotherapies
Researchers at Johns Hopkins University in Baltimore have taken...
Interview: CEO Per Norlén about the 350 million SEK issue and Alligator's IPO
The research company Alligator Bioscience, which develops antibody-based drugs for...
RhoVac: Cancer vaccine innovative treatment against metastases
A way for cancer cells to survive in the body...
American giant deal in cancer immunotherapy
Jounce Therapeutics Inc., an American Cambridge startup with only...